Menssana Research's experimental 6-minute breath-test identifies women with early stage breast cancer or an abnormal mammogram, researchers report.
MASSDEVICE ON CALL — Diagnostics maker Menssana Research is making promising progress with a breath-test that the company says can identify at-risk breast cancer cases in just 6 minutes.
In a study of nearly 250 women at 3 centers in New Jersey, Washington and the Netherlands the test was able to accurately identify women with early stage breast cancer or with abnormal mammogram, Menssana said.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1jUQDLc
Cap comentari:
Publica un comentari a l'entrada